Himanshu Lukka

1.9k total citations
34 papers, 540 citations indexed

About

Himanshu Lukka is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Himanshu Lukka has authored 34 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 13 papers in Radiation and 7 papers in Surgery. Recurrent topics in Himanshu Lukka's work include Prostate Cancer Treatment and Research (21 papers), Prostate Cancer Diagnosis and Treatment (15 papers) and Advanced Radiotherapy Techniques (13 papers). Himanshu Lukka is often cited by papers focused on Prostate Cancer Treatment and Research (21 papers), Prostate Cancer Diagnosis and Treatment (15 papers) and Advanced Radiotherapy Techniques (13 papers). Himanshu Lukka collaborates with scholars based in Canada, United States and United Kingdom. Himanshu Lukka's co-authors include Dean Daya, Philip B. Clement, Howard M. Sandler, William U. Shipley, Daniel Hunt, Padraig Warde, Jean-Paul Bahary, Pierre Major, T. Waldron and M. Patel and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Human Pathology.

In The Last Decade

Himanshu Lukka

31 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Himanshu Lukka Canada 12 353 124 97 79 70 34 540
Palak Popat India 11 242 0.7× 116 0.9× 105 1.1× 88 1.1× 74 1.1× 47 419
J. Wylie United Kingdom 13 219 0.6× 87 0.7× 134 1.4× 86 1.1× 126 1.8× 30 552
Shane Mesko United States 12 192 0.5× 119 1.0× 79 0.8× 53 0.7× 74 1.1× 37 368
Ah Ram Chang South Korea 12 166 0.5× 147 1.2× 145 1.5× 53 0.7× 163 2.3× 44 510
Anupama Chundury United States 11 160 0.5× 104 0.8× 89 0.9× 98 1.2× 54 0.8× 39 356
S. Jorcano Spain 14 517 1.5× 204 1.6× 76 0.8× 55 0.7× 59 0.8× 35 678
Mitsuhiro Takahashi Japan 12 175 0.5× 115 0.9× 138 1.4× 94 1.2× 85 1.2× 36 441
Emilie Bogart France 12 242 0.7× 109 0.9× 107 1.1× 24 0.3× 107 1.5× 35 437
Razvan Galalae Germany 17 583 1.7× 436 3.5× 178 1.8× 155 2.0× 92 1.3× 43 873
Madoka Morota Japan 12 183 0.5× 79 0.6× 192 2.0× 101 1.3× 104 1.5× 23 429

Countries citing papers authored by Himanshu Lukka

Since Specialization
Citations

This map shows the geographic impact of Himanshu Lukka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Himanshu Lukka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Himanshu Lukka more than expected).

Fields of papers citing papers by Himanshu Lukka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Himanshu Lukka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Himanshu Lukka. The network helps show where Himanshu Lukka may publish in the future.

Co-authorship network of co-authors of Himanshu Lukka

This figure shows the co-authorship network connecting the top 25 collaborators of Himanshu Lukka. A scholar is included among the top collaborators of Himanshu Lukka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Himanshu Lukka. Himanshu Lukka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pollack, Alan, Marla Johnson, J. Proudfoot, et al.. (2025). Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial.. Journal of Clinical Oncology. 43(5_suppl). 399–399. 2 indexed citations
2.
Kwak, Lucia, Praful Ravi, John G. Armstrong, et al.. (2024). Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials. Journal of Clinical Oncology. 42(18). 2132–2138. 6 indexed citations
3.
Michalski, Jeff M., Jennifer Moughan, James A. Purdy, et al.. (2023). Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). S4–S5. 3 indexed citations
4.
Parpia, Sameer, Eileen Rakovitch, Lynn Chang, et al.. (2023). Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trial. The Breast. 68. 189–193. 4 indexed citations
7.
Schep, Daniel, Ian S. Dayes, Himanshu Lukka, et al.. (2023). Evaluation of Volumetric Response Assessment From SABR for Renal Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 119(3). 832–837. 3 indexed citations
8.
Mesci, Aruz, et al.. (2022). Salvage radiotherapy following HiFU: An institutional series and literature review. Journal of Medical Imaging and Radiation Oncology. 66(6). 847–852. 1 indexed citations
9.
Lukka, Himanshu, Snehal Deshmukh, Deborah Watkins Bruner, et al.. (2022). Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 116(4). 770–778. 6 indexed citations
11.
Hallemeier, Christopher L., Peixin Zhang, Thomas M. Pisansky, et al.. (2019). Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials. International Journal of Radiation Oncology*Biology*Physics. 104(5). 1057–1065. 7 indexed citations
12.
Pinthus, Jehonathan H., Laurence Klotz, Himanshu Lukka, et al.. (2016). The RADICAL-PC trial.. Journal of Clinical Oncology. 34(2_suppl). 178–178. 3 indexed citations
13.
Arsenault, Julie, Sameer Parpia, Harold Reiter, et al.. (2015). Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 93(3). S59–S59. 5 indexed citations
14.
Lukka, Himanshu, Deborah Watkins Bruner, Jean-Paul Bahary, et al.. (2015). Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 94(1). 2–2. 17 indexed citations
15.
Pisansky, Thomas M., Daniel Hunt, Leonard G. Gomella, et al.. (2014). Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910. Journal of Clinical Oncology. 33(4). 332–339. 79 indexed citations
17.
Segal, Roanne, et al.. (2001). Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline.. PubMed. 8(1). 1184–92. 15 indexed citations
18.
Covens, Al, Gigi Thomas, Peter J. Shaw, et al.. (1997). A Phase II Study of Leuprolide in Advanced/Recurrent Endometrial Cancer. Gynecologic Oncology. 64(1). 126–129. 62 indexed citations
19.
Daya, Dean, Himanshu Lukka, & Philip B. Clement. (1992). Primitive neuroectodermal tumors of the uterus: A report of four cases. Human Pathology. 23(10). 1120–1129. 69 indexed citations
20.
Lukka, Himanshu, Christopher J. Moore, & Rosemary Hunter. (1987). The relationship between the bladder and the cervix in patients undergoing intracavitary therapy. British Journal of Radiology. 60(712). 355–359. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026